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Aim: This pilot study aimed to evaluate the individual features of the metabolic syndrome 
(MeS) and its frequency in Qatari schoolchildren aged 6–12 years.
Background: MeS has a strong future risk for development of diabetes and cardiovascular 
diseases. Childhood obesity is increasing the likelihood of MeS in children.
Methods: The associated features of MeS were assessed in 67 children. They were recruited 
from the outpatient pediatric clinic at Hamad Medical Corporation, Qatar. Height, weight, and 
waist circumference were measured and body mass index was calculated for each child.   Fasting 
blood glucose, total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density 
lipoprotein cholesterol and triglycerides (TG) were measured. MeS was defined according to 
the National Cholesterol Education Program Adult Treatment Panel III (NCEP-III) which was 
modified by Cook with adjustment for fasting glucose to $5.6 mM according to recommenda-
tions from the American Diabetes Association.
Results: The overall prevalence of MeS according to NCEP-III criteria was 3.0% in chil-
dren aged 6–12 years. Overweight and obesity was 31.3% in children aged 6–12 years, 
according to the International Obesity Task Force criteria. The prevalence of MeS was 
9.5% in overweight and obese subjects. Increased TG levels represented the most frequent 
abnormality (28.4%) in metabolic syndrome features in all subjects, followed by HDL-C 
(19.4%) in all subjects.
Conclusion: Increased TG levels and low HDL-C were the most frequent components of this 
syndrome. This study showed a significant prevalence of MeS and associated features among 
overweight and obese children. The overall prevalence of MeS in Qatari children is in accordance 
with data from several other countries.
Keywords: metabolic syndrome, National Cholesterol Education Program Adult Treatment 
Panel III, schoolchildren, Qatar
Introduction
Several studies have demonstrated that cardiovascular diseases (CVD) begin early 
in childhood and atherosclerotic changes may occur early in the life of children 
with lipid abnormalities.1,2 Metabolic syndrome (MeS) clusters consist of obesity, 
insulin resistance, hypertension, impaired glucose tolerance, hyperinsulinemia and 
dyslipidemia associated with low high density lipoprotein cholesterol (HDL-C) and 
hypertriglyceridemia.3
Childhood obesity is increasing worldwide including in Qatar,4,5 thus increasing the 
likelihood of MeS in children.6 Physicians need to screen and detect early manifesta-
tions of MeS clusters during childhood, particularly among obese children.International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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The State of Qatar is a small country in the Arab Gulf 
area. Data relevant to MeS are limited among Qatari 
schoolchildren, therefore this study aimed to investigate 
the frequency of MeS and its associated features in 6 to 12 
year old Qatari children.
Methods
This cross-sectional study involved a total of 67 subjects 
aged 6–12 years (30 males and 37 females). A convenient 
sample was recruited from the pediatric outpatient clinic at 
Hamad Medical Corporation (HMC), Qatar, from March 
2005 to August 2005. The study was approved by the 
Research Ethics committee of HMC and informed consent 
was obtained.
Body weight was measured, using a Seca 634 digital 
electronic platform scale (Birmingham, UK) with precision 
to 0.1 kg, following a standardized procedure (lightly 
dressed, without shoes). Standing height was measured to 
the nearest 0.1 cm with the use of a stadiometer. Body mass 
index (BMI) was calculated by dividing weight in kg by 
height squared in meters. Waist circumference (WC) was 
measured in duplicate by means of a nonelastic flexible tape, 
with subjects standing, at the smallest abdominal position 
between the iliac crest and the lower rib margin at the end 
of normal expiration. The measurements were recorded to 
the nearest 0.5 cm. Blood pressure (BP) was measured in 
triplicate on the arm with the patient seated after rest, using 
a digital sphygmomanometer and appropriate sized cuff. A 
fasting blood sample was drawn. Blood glucose, total cho-
lesterol (TC), triglycerides (TG), high density lipoprotein 
cholesterol (HDL-C) and low density lipoprotein cholesterol 
(LDL-C) were determined as previously published.7
MeS was defined according to the National Cholesterol 
Education Program Adult Treatment Panel III (NCEP-III)8 
which was modified by Cook,9 with adjustment for fast-
ing glucose to $5.6 mM according to American Diabetes 
Association recommendations.10 MeS required the pres-
ence of 3 components out of 5 of the following criteria:
1.  Abdominal obesity with waist circumference $ 90th per-
centile for age/gender, according to previous studies.9,11 A 
recent study evaluating the waist circumference reference 
values for screening cardiovascular risk factors in Chinese 
children and adolescents aged 7–18 years, indicated a 
slight increasing trend of cardiovascular risk factors 
starting from the 75th percentile of waist circumference 
in the study population, while a significant increasing 
trend occurred from the 90th percentile.12
2.  Impaired fasting glucose (glucose $ 5.6 mM).
3.  Systolic/diastolic blood pressure ($90th percentile for 
height, age, and gender).
4.  TG $ 1.24 mM.
5.  HDL-C # 1.036 mM or below the 5th percentile.
The International Obesity Task Force (IOTF) criterion 
was adopted for classification of children as overweight and 
obese.13
Statistical analysis
Statistical evaluation was performed with SPSS, PC (pro-
gram for Windows, version 19, SPSS Inc, Chicago, IL). 
Student’s t-test was used for comparison between groups. 
Comparisons of frequencies of individual components and 
the numbers of MeS were performed using the Chi-Square 
test. A level of P , 0.05 was considered statistically 
significant.
Results
The anthropometric, clinical, and biochemical characteristics 
of the 67 children are presented by gender in Table 1. Boys 
had a statistically significant higher value for TG than girls. 
Using IOTF, 10 boys (14.9%) and 11 girls (16.4%) were 
overweight and obese.
Table 2 and Figure 1 present the individual compo-
nents of MeS by gender and overweight and obesity status. 
Hypertriglyceridemia was the most frequent component 
of MeS (28.4%) among all subjects, and was significantly 
higher among boys than girls. The second order of frequency 
among MeS components was low HDL-C (19.4%), followed 
by hyperglycemia (16.4%), then hypertension (10.5%) and 
lastly by abdominal obesity (4.5%). The overall incidence 
of MeS among all children was 3.0%. The two subjects 
presenting with MeS were obese. The number of compo-
nents of MeS was higher in boys than girls, (33.3% versus 
29.7%), (30.0% versus 13.5%) and (3.3% versus 2.7%) for 
one, two and three components respectively. The number of 
components of MeS was significantly higher in overweight 
and obese children than non-overweight and non-obese 
children, (42.9% versus 17.4%), (38.1% versus 13.0%) 
and (9.5% versus 0.0%) for one, two and three components 
respectively (Figure 2).
Discussion
The current study revealed that 3.0% of all study subjects 
had MeS according to NCEP-III criteria,8 modified by Cook’s 
criteria9 with adjustment for fasting glucose to $5.6 mM International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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according to American Diabetes   Association recommenda-
tions.10 Though direct comparison across studies is difficult 
since the definitions of the syndrome are different, the 
results of the current study are in agreement with a previ-
ous study by Cruz and Goran, which demonstrated that the 
overall prevalence of MeS in children was 3.0% to 4.0% in 
the USA.14 The current results are similar to data among 
Turkish schoolchildren aged 10–19 years (2.3%) according 
to International Diabetes Foundation (IDF) and NECP-III 
criteria.15 Using a definition comparable to that projected 
in NECP-III criteria, a prevalence of 3.6% in children 8–17 
years of age was reported by investigators from the Bogalusa 
Heart Study.16 Using the IDF definition, the prevalence of 
MeS in Jordanian children 10–15 years old was (1.4%).17 
The prevalence of MeS in Caucasian children was reported 
to be 6.0% to 39.0%,18 while it was 6.7% in Korean children 
and adolescents.19
Childhood obesity is increasing the likelihood of MeS 
in children.5 Our results report a high prevalence of MeS 
(9.5%) and its components among overweight and obese 
children (Figure 2). This finding is similar to other studies 
which demonstrated much higher prevalence rates of MeS 
in children who were overweight or obese.8,20–22
The reliability of diagnostic criteria for MeS in chil-
dren has been questioned. It has been found that they 
require modification to be applicable to children.23 This 
may account in part for the discrepancies in prevalence 
between   different populations. However, this study, like 
a number of   others, identified the prevalence of various 
abnormalities (all included within the criteria) separately. 
In the whole sample studied, the most frequently found 
abnormality (Figure 1) was hypertriglyceridemia (28.4%) 
followed by low HDL (19.4%). These findings support 
those of other studies indicating that the most common 
abnormality is high triglycerides and low HDL cholesterol 
in US children.8
This study has strengths and limitations. An impor-
tant strength is that it provides additional data on Qatari 
Table 1 Descriptive characteristics of a sample of Qatari school children 6 to 12 years-old by gender
All Boys (n = 30) Girls (n = 37) P 
Age (Years) 8.34 (7.81–8.88) 8.40 (7.55–9.25) 8.30 (7.59–9.01) 0.849
Weight (kg) 31.05 (28.14–33.95) 31.96 (27.77–36.16) 30.30 (26.11–34.49) 0.387
height (cm) 131.10 (1.28–1.35) 132.90 (128.0–137.8) 129.70 (125.0–134.5) 0.148
BMI (kg/m2) 17.41 (16.52–18.31) 17.56 (16.29–18.86) 17.28 (15.98–18.57) 0.734
ow/ob, n (%) 21.00 (31.3%) 10.00 (14.9%) 11.00 (16.4%) 0.752
WC (cm) 57.42 (54.79–60.05) 58.82 (54.36–63.27) 56.28 (53.03–59.54) 0.200
SBP (mm hg) 100.08 (97.33–102.82) 102.07 (97.56–106.58) 98.46 (94.66–101.93) 0.120
DBP (mm hg) 54.57 (52.19–56.94) 54.20 (50.57–57.83) 54.87 (51.57–58.16) 0.766
Glucose (mM) 4.92 (4.72–5.11) 4.98 (4.69–5.27) 4.87 (4.59–5.14) 0.847
TC (mM) 4.38 (4.18–4.58) 4.29 (3.92–4.65) 4.46 (4.24–4.67) 0.655
TG (mM) 1.11 (0.95–1.27) 1.29 (0.99–1.58) 0.97 (0.80–1.13) 0.044*
hDL-C (mM) 1.59 (1.45–1.72) 1.50 (1.32–1.68) 1.66 (1.46–1.86) 0.578
LDL-C (mM) 2.20 (2.02–2.39) 2.18 (1.83–2.54) 2.2 (2.02–2.42) 0.722
Notes: Numerical data are presented as mean values (95.0% lower-upper confidence interval), and Student’s t-test was used for the difference of continuous variables 
between genders adjusted for age and gender. Categorical data are presented by number and %, and a Chi-square test was used to evaluate the difference between genders. 
P value is significant at #0.05.
Abbreviations: BMI, body mass index; WC, waist circumference; MeS, metabolic syndrome; ow and ob, overweight and obese; TC, total cholesterol; hDL-C, high-density 
lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TG, triglycerides; SBP, systolic blood pressure; DBP, diastolic blood pressure.
Table 2 Frequency of individual MeS components in all subjects and by gender
Prevalence of  
individual MeS components
All (n = 67) Boys (n = 30) Girls (n = 37) P
MeS, n (%) 2 (3.0) 1 (3.3) 1 (2.7) –
high WC 3 (4.5%) 3 (10.0%) 0 (0.0%) 0.046
hyperglycemia 11 (16.4%) 5 (16.7%) 6 (16.2%) 0.961
Low hDL-C 13 (19.4%) 6 (20.0%) 7 (18.2%) 0.911
high TG 19 (28.4%) 10 (33.3%) 5 (13.5%) 0.048
high blood pressure 7 (10.5%) 4 (13.3%) 3 (8.1%) 0.120
Notes: Categorical data are presented by number (%). A Chi-square test was used to evaluate the difference between genders. P value is significant at #0.05.
Abbreviations: WC, waist circumference; MeS, metabolic syndrome; hDL-C, high-density lipoprotein cholesterol; TG, triglycerides.International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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  schoolchildren relating to MeS, which was previously 
  lacking. The major limitations are the small sample size and 
an ongoing debate on the accuracy of diagnosing the MeS in 
children younger than 10 years old.
In conclusion, our results indicate that though the preva-
lence of MeS is low overall in Qatari children, overweight and 
obese children had higher rates of MeS than non-over weight 
and non-obese children. A large proportion of Qatari schoolchil-
dren had one or two metabolic abnormalities. Further studies 
are needed, with larger sample sizes, including measurements 
of hormones and biomarkers known to be involved in patho-
genesis and identification of MeS in Qatari school children.
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Figure 2 The frequency of clustering of metabolic abnormalities among Qatari school children aged between 6 and 12 years according to overweight/obesity status.
Notes: The P value indicates the difference in frequency of clustering of MeS components between non-ow and non-ob and ow/ob children. A level of P , 0.05 is statistically significant.
Abbreviations: ow and ob, overweight and obese; non-ow and non-ob, non-overweight and non-obese.
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Figure 1 Frequency of individual MeS components (%) in all subjects and according to overweight/obesity status.
Notes: The P value indicates the difference in frequency distribution of individual MeS components between non-ow & non-ob and ow/ob children. A level of P , 0.05 is 
statistically significant.
Abbreviations: WC, waist circumference; MeS, metabolic syndrome; ow and ob, overweight and obese; non-ow and non-ob, non-overweight and non-obese; hDL-C, 
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